TotalMarketCap

Mesoblast

MESONasdaq AustraliaHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.833 B

$14.09 -1.40%

Close of 6 Nov 2026

As of 6 Nov 2026, Mesoblast (MESO) has a market capitalization of $1.83B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1,296,862,776

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #35Replimune GroupREPL$1.90B
  2. #36Vir BiotechnologyVIR$1.89B
  3. #37MesoblastMESO$1.83B
  4. #38Maze TherapeuticsMAZE$1.80B
  5. #39AlvotechALVO$1.78B

What if Mesoblast were worth as much as…

Open the what-if tool →

Gold $28.2T

$217,065.11

Per share 15,406× higher

Bitcoin $1.53T

$11,745.02

Per share 834× higher

Apple $5.02T

$38,557.79

Per share 2,737× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Mesoblast are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.